Naturite Agro Products Limited, a manufacturer specializing in natural spice extracts, oleoresins, and herbal products, has announced plans for a rights issue to raise up to Rs 26 crore. The company, incorporated in 1994 and led by promoter Siva Dharma Teja Yadlapalli, is preparing to offer additional equity to eligible shareholders. As of the initial board approval granted on 12 October 2026, specific schedule dates, issue pricing, and entitlement ratios remain to be finalized.
Company Overview and Business Operations
Headquartered in Telangana, Naturite Agro Products operates within the natural ingredients and food processing sectors. The company produces a range of items including Capsicum Oleoresin, Natural Pure Capsaicin, Paprika Oleoresin, Turmeric Oleoresin, and Curcumin Powder. These components are supplied to various industries, spanning food processing, pharmaceuticals, cosmetics, and healthcare applications.
The enterprise maintains a manufacturing facility located in Shamirpet Mandal, Medchal District, Telangana, which features a production capacity of approximately 2,500 tonnes. Demonstrating quality standards and regulatory compliance, the manufacturing plant holds a Spice House Certificate issued by the Spices Board of India. Beyond domestic operations, the business reaches international markets, exporting its product portfolio to Southeast Asia, the Americas, Africa, the Middle East, Japan, and South Korea.
In addition to its industrial botanical extractions, Naturite has diversified into consumer-facing product categories. Its expanded catalog includes ready-to-eat foods, incense sticks, hing (asafoetida), toothpowder, and soya products, providing alternative revenue streams alongside its core spice derivatives segment.
Rights Issue Structure and Key Parameters
The capital raise is structured as a rights issue targeting an aggregate amount of Rs 26 crore. Shares carry a face value of Rs 5 each and are proposed to be listed on the Bombay Stock Exchange (BSE). Venture Capital and Corporate Investments Private Limited has been appointed as the registrar to manage the offer processes.
| Rights Issue Parameter | Details |
|---|---|
| Total Issue Size | Rs 26 crore |
| Face Value | Rs 5 per share |
| Listing Platform | BSE |
| Approval Date | 12 October 2026 |
| Market Price on Approval | Rs 78.47 per share |
| Registrar | Venture Capital and Corporate Investments Private Limited |
Objectives of the Issue
According to the corporate disclosures, the proceeds generated from the rights offering will be allocated toward specific corporate and operational requirements:
- Repayment or pre-payment of certain unsecured loans amounting to Rs 10 crore.
- Funding working capital requirements up to Rs 10 crore.
- General corporate purposes totaling Rs 5.25 crore.
Financial Performance Overview
A review of the standalone financial data indicates notable top-line expansion in recent periods, accompanied by bottom-line fluctuations. Revenue grew from Rs 9.52 crore in FY 2024 to Rs 8.56 crore in FY 2025, before scaling significantly to Rs 35.64 crore in FY 2026. Concurrently, expenses shifted from Rs 9.01 crore in FY 2024 and Rs 11.77 crore in FY 2025 to Rs 35.21 crore in FY 2026.
Net income figures reflect a profit of Rs 0.35 crore in FY 2024, followed by net losses of Rs 2.54 crore in FY 2025 and Rs 0.75 crore in FY 2026.
| Financial Metric (Standalone) | FY 2024 (Rs Cr) | FY 2025 (Rs Cr) | FY 2026 (Rs Cr) |
|---|---|---|---|
| Revenue | 9.52 | 8.56 | 35.64 |
| Expenses | 9.01 | 11.77 | 35.21 |
| Net Income / PAT | 0.35 | (2.54) | (0.75) |
Market and Business Analysis
Financial and Valuation Dynamics
Based on the reported financial data, Naturite Agro Products has demonstrated substantial revenue acceleration in the latest fiscal year, moving from single-digit figures to over Rs 35 crore. However, the expense structure has closely mirrored this top-line expansion, resulting in consecutive net losses of Rs 2.54 crore in FY 2025 and Rs 0.75 crore in FY 2026. The narrowing net loss in FY 2026 alongside higher revenues suggests improving operational leverage, though sustained profitability remains a key factor to monitor. The market price of the equity shares stood at Rs 78.47 per share at the time of the rights issue approval.
Capital Deployment and Balance Sheet Impact
The proposed deployment of the Rs 26 crore proceeds targets two immediate operational needs: debt reduction through unsecured loan repayments of Rs 10 crore and liquidity support via working capital allocation of Rs 10 crore. Allocating a substantial portion of capital to debt servicing can potentially ease ongoing financial expenses and strengthen the balance sheet structure. Meanwhile, the working capital injection is designed to support the expanded scale of operations stemming from the company’s manufacturing facility and international footprint.
Business Scale and Diversification Risks
The company maintains an established presence in the spice derivatives and oleoresin market, supported by certifications from the Spices Board and an international export client base across Southeast Asia, the Americas, Africa, and East Asia. While diversification into consumer goods like ready-to-eat items and incense sticks broadens market reach, industrial ingredient manufacturing remains the primary operational driver. Investors evaluating rights offerings typically assess how effectively management can convert top-line growth into consistent net profitability while managing working capital requirements.
| Analysis Aspect | Observation | Interpretation |
|---|---|---|
| Revenue Growth | Scaled to Rs 35.64 crore in FY 2026 | Demonstrates strong top-line demand expansion in core and diversified segments. |
| Profitability Trend | Losses of Rs (2.54) crore and Rs (0.75) crore in FY 2025 and FY 2026 | Indicates that operational scaling has thus far incurred high expenses relative to revenues. |
| Debt Reduction | Rs 10 crore allocated for unsecured loans | Aims to relieve debt-related pressures on the balance sheet. |
Key Takeaways
- Naturite Agro Products is executing a rights issue to raise up to Rs 26 crore, with specific pricing and entitlement details pending finalization.
- The company operates in the spice oleoresins and natural extracts industry with a 2,500-tonne capacity plant in Telangana and international export channels.
- Standalone revenue expanded to Rs 35.64 crore in FY 2026, though the company recorded a net loss of Rs 0.75 crore during the same period.
- Proceeds are earmarked for unsecured loan repayment (Rs 10 crore), working capital (Rs 10 crore), and general corporate purposes (Rs 5.25 crore).
- The market price of the equity shares was recorded at Rs 78.47 per share at the time of the board’s approval on 12 October 2026.
Frequently Asked Questions
The rights issue aims to raise up to Rs 26 crore.
The rights issue was approved on 12 October 2026.
The proceeds will be used for the repayment of unsecured loans (Rs 10 crore), working capital requirements (Rs 10 crore), and general corporate purposes (Rs 5.25 crore).
Naturite Agro Products reported a standalone revenue of Rs 35.64 crore in FY 2026.
The manufacturing facility is located in Shamirpet Mandal, Medchal District, Telangana.
The registrar for the issue is Venture Capital and Corporate Investments Private Limited.
The face value is Rs 5 per share.
The shares are proposed to be listed on the Bombay Stock Exchange (BSE).
